Trevena
TRVN
$0.42
Share price
-9.11%
Change (1 day)
-77.78%
Change (1 year)
Categories
Market capitalization of Trevena (TRVN)
Market cap: $0.06 Billion
As of June 2022 Trevena has a market cap of $0.06 Billion. This makes Trevena the world's 5968th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Trevena from 2014 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.07 B | -24.45% |
| 2021 | $0.09 B | -72.01% |
| 2020 | $0.34 B | 332.19% |
| 2019 | $0.07 B | 123.8% |
| 2018 | $0.03 B | -64.49% |
| 2017 | $0.09 B | -67.61% |
| 2016 | $0.30 B | -42.31% |
| 2015 | $0.53 B | 127.32% |
| 2014 | $0.23 B |
End of Day market cap according to different sources
On Jun 23rd, 2022 the market cap of Trevena was reported to be:
$0.07 Billion
$0.07 Billion
$0.07 Billion
$0.07 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $131.07 B | 189,306.42% | 🇺🇸 USA |
 Merck MRK | $235.50 B | 340,210.35% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | $0.45 B | 563.16% | 🇺🇸 USA |
 Cytokinetics
CYTK | $4.04 B | 5,748.03% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $0.02 B | -61.73% | 🇺🇸 USA |
 Cara Therapeutics
CARA | $0.50 B | 627.16% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | $6.16 B | 8,808.92% | 🇺🇸 USA |